Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ESP Catheter-University of Minnesota refers to a specific regional anesthesia protocol and delivery system evaluated by the University of Minnesota for the management of pain in patients with multiple rib fractures. The intervention involves the ultrasound-guided placement of a catheter into the erector spinae plane (ESP), a fascial space deep to the erector spinae muscle. The protocol utilizes a combination of amide-type local anesthetics: an initial loading bolus of bupivacaine (0.25%) followed by a continuous or programmed intermittent bolus infusion of ropivacaine (0.2%). These agents function by blocking voltage-gated sodium channels on neuronal membranes, thereby inhibiting the initiation and conduction of action potentials in the dorsal and ventral rami of the spinal nerves. This results in multi-dermatomal sensory blockade and effective analgesia, serving as an alternative to systemic opioids or other regional techniques like thoracic epidurals or cryoablation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ESP Catheter-University of Minnesota.